Clinical Trials
3 trialsNCT03816358 2026-05-13
Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT03102320 2022-06-30
ARCS-Multi
Bayer
Phase 1 Completed
NCT03023722 2021-10-28
Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer
Yale University
Phase 2 Completed